Queen Margaret University logo
    • Login
    View Item 
    •   QMU Repositories
    • eResearch
    • School of Health Sciences
    • Physiotherapy
    • View Item
    •   QMU Repositories
    • eResearch
    • School of Health Sciences
    • Physiotherapy
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Access and use of clinical services and disease modifying therapies by people with progressive Multiple Sclerosis in the United Kingdom

    View/Open
    Accepted version (63.06Kb)
    Date
    2017-08-30
    Author
    Campbell, Evan
    Coulter, Elaine H.
    Mattison, Paul
    McFadyen, Angus
    Miller, Linda
    Paul, Lorna
    Metadata
    Show full item record
    Citation
    Campbell, E., Coulter, E., Mattison, P., McFadyen, A., Miller, L. & Paul, L. (2017) Access and use of clinical services and disease modifying therapies by people with progressive Multiple Sclerosis in the United Kingdom. International Journal of MS Care, 19(6), pp. 275-282.
    Abstract
    Background: According to current UK guidelines everyone with progressive MS should have access to an MS Specialist but levels of access and use of clinical services is unknown. Objective: To investigate access to MS Specialists, use of clinical services and Disease Modifying Therapies (DMT) by people with progressive MS in the United Kingdom. Methods: A UK wide, online survey was conducted via the UK MS Register. Inclusion criteria: age over 18 years, primary or secondary progressive MS and a member of the UK MS Register. Participants were asked about access to MS Specialists; recent clinical service use; receipt of regular review and current and previous DMT use. Participant demographics; quality of life and disease impact measures were supplied from the UK MS Register. Results: In total 1298 participants responded: 5% were currently taking DMT; 23% had previously taken DMT; and 95% reported access to an MS Specialist. Most utilised services were: MS Doctor/Nurse (50%), General Practitioner (45%), and Physiotherapist (40%). Seventy-four percent received a regular review although 37% received theirs less than annually. Current DMT use was associated with better quality of life but past DMT use was associated with poorer quality of life and higher impact of disease. Conclusion: Access to, and use of, MS Specialists was high. However a gap in service provision was highlighted in both receiving and frequency of regular reviews.
    Official URL
    https://doi.org/10.7224/1537-2073.2017-022
    URI
    https://eresearch.qmu.ac.uk/handle/20.500.12289/4837
    Collections
    • Physiotherapy

    Queen Margaret University: Research Repositories
    Accessibility Statement | Repository Policies | Contact Us | Send Feedback | HTML Sitemap

     

    Browse

    All QMU RepositoriesCommunities & CollectionsBy YearBy PersonBy TitleBy QMU AuthorBy Research CentreThis CollectionBy YearBy PersonBy TitleBy QMU AuthorBy Research Centre

    My Account

    LoginRegister

    Queen Margaret University: Research Repositories
    Accessibility Statement | Repository Policies | Contact Us | Send Feedback | HTML Sitemap